Supriya Lifescience's ₹700-crore initial public offering (IPO) will open on December 16 at a price band of ₹265-274 per share. The offer comprises fresh issue of equity shares worth ₹200 crore and an offer-for-sale of up to ₹500 crore by its promoter. Currently, the promoter holds 99.26% stake in the company, which manufactures and supplies active pharmaceutical ingredients (APIs).